Nitric oxide and the regulation of blood pressure in the hypertension- prone and hypertension-resistant Sabra rat

Hypertension

Volumn 28, Issue 3, 1996, Pages 367-371

  Rees, Daryl ^a   Ben Ishay, Drori ^b   Moncada, Salvador ^a,c  

^a WELLCOME RESEARCH LABORATORIES   (United Kingdom)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c Cruciform Project   (United Kingdom)

Author keywords

blood pressure; endothelium; nitric oxide; rats, Sabra

Indexed keywords

ACETYLCHOLINE; CALCIUM; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PHENYLEPHRINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG MECHANISM; DRUG POTENCY; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; VASODILATATION;

EID: 0029815114     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.3.367     Document Type: Article

References (29)

1. Shepherd JT. Increased systemic vascular resistance and primary hypertension: the expanding complexity. J Hypenens. 1990;8(suppl 7):S15-S27.
2. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989;86:3375-3378.
3. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
4. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
5. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992;10:1025-1031.
6. w-nitro-L-arginine. Hypertension. 1991;18:683-688.
7. G-Monomethyl-L-arginine-induced presser response at developmental and established stages in spontaneously hypertensive rats. J Pharmacol Exp Ther. 1991;259:52-57.
8. Koller A, Huang A. Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats. Circ Res, 1994;74:416-421.
9. Kelm M, Feelisch M, Krebber T, Motz W, Strauer BE. The role of nitric oxide in the regulation of coronary vascular resistance in arterial hypertension: comparison of normotensive and spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1992;20(suppl 12):S183-S186.
10. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ. Molecular cloning and characterization of the constitutive bovine aortic endothetial cell nitric oxide synthase. J Clin Invest. 1992;90:2092-2096.
11. Moncada S, Palmer RMJ, Higgs EA. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension. 1988;12:365-372.
12. Navarro J, Sanchez A, Saiz J, Ruilope LM, Garcia-Estan J, Romero JC, Moncada S, Lahera V. Hormonal, renal and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am J Physiol. 1994;267:R1516-R1521.
13. Ben-Ishay D, Mekler J, Saliternick-Vardi R. Sabra hypertensionprone and hypertension-resistant rats. Hypertension. 1987;9(suppl I):I-24-I-26.
14. 2-adrenoceptors for epinephrine in Sabra salt-sensitive and salt-resistant rats. Am J Hypertens. 1991;4:267-270.
15. Yagil Y, Ben-Ishay D, Wald H, Popovtzer MM. Water handling by the Sabra hypertension prone (SBH) and resistant (SBN) rats. Pflugers Arch. 1985;404:61-66.
16. Yagil Y, Mekler J, Wald H, Popovtzer MM, Ben-Ishay D. Sodium handling by the Sabra hypertension prone (SBH) and resistant (SBN) rats. Pflugers Arch. 1986;407:547-551.
17. Ben-Ishay D, Yagil Y. The Sabra hypertension-prone and -resistant strains. In: Ganten D, de Jong W, eds. Handbook of Hypertension, 16: Experimental and Genetic Models of Hypertension. Amsterdam, Netherlands: Elsevier Science Publishers; 1994:272-299.
18. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterisation of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1991;101:746-752.
19. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
20. Moncada S, Rees DD, Schulz R, Palmer RMJ. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci U S A. 1991;88:2166-2170.
21. Chen PY, Sanders PW. L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991;88:1559-1567.
22. Luscher TF, Raij L, Vanhoutte PM. Effect of hypertension and its reversal on endothelium-dependent relaxations in the rat aorta. J Hypertens. 1987;5(suppl 5):S153-S155.
23. Chiu EKY, Wang H, McNeill JR. Role of sodium and water excretion in the antihypertensive effect of vasopressin in the spontaneously hypertensive rat. Can J Physiol Pharmacol. 1992;70:1309-1314.
24. Stier CT, Itskovitz HD, Chen Y-H. Urinary dopamine and sodium excretion in spontaneously hypertensive rats. Clin Exp Hypertens. 1993;15:105-123.
25. G-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol. 1991;261:F1033-F1037.
26. Shultz PJ, Tolins JP. Adaptation to increased dietary salt intake in the rat: role of endogenous nitric oxide. J Clin invest. 1993;91:642-650.
27. Deng X, Welch WJ, Wilcox CS. Renal vasoconstriction during inhibition of NO synthase: effects of dietary salt. Kidney Int. 1994;76:639-646.
28. Hayakawa H, Hirata Y, Suzuki E, Sugimoto T, Matsuoka H, Kikuchi K, Nagano T, Hirobe M, Sugimoto T. Mechanisms for altered endothelium-dependent vasorelaxation in isolated kidneys from experimental hypertensive rats. Am J Physiol. 1993;264:H1535-H1541.
29. Simpson FO. Blood pressure and sodium intake. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. 2nd ed. New York, NY: Raven Press Publishers; 1995:273-281.